Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Revlimid

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Revlimid was produced by Celgene.

BMS' Empliciti approved by FDA for multiple myeloma

BMS' Empliciti approved by FDA for multiple myeloma time before their disease worsened (19.4 months) compared to participants taking only Revlimid and dexamethasone (14.9 months). ... All told, 78.5% of those taking the Empliciti regimen experienced a complete or partial shrinkage of their tumours

FDA clears Takeda's oral multiple myeloma drug

FDA clears Takeda's oral multiple myeloma drug Ninlaro ( ixazomib; formerly MLN9708) has been cleared for use in combination with Celgene's immunomodulatory drug Revlimid (lenalidomide) and dexamethasone in patients with the blood cancer who have been treated with

Amgen’s Kyprolis approved in Europe

Amgen’s Kyprolis approved in Europe Multiple myeloma drugwins licence three years after gaining US approval. Amgen's Kyprolis has been approved in Europe in combination with Celgene's Revlimid and dexamethasone for the treatment of adults

J&J gets FDA green light for myeloma drug Darzalex

J&J gets FDA green light for myeloma drug Darzalex like Celgene's Revlimid (lenalidomide). ... well as the POLLUX trial which pairs the antibody with Cegene's Revlimid. .

Amgen's Kyprolis and Blincyto on track for European approval

Amgen's Kyprolis and Blincyto on track for European approval Kyprolis (carfilzomib) was recommended for use in combination with Celgene's Revlimid (lenalidomide) and dexamethasone for patients with multiple myeloma who have received at least one prior therapy.

[ Previous 5 results ] 7 8 9 10 11 12 13 14 15 16 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics